EUVIMEDEUVIMED entdecken
Crossref

ETV1 genetic polymorphisms as a candidate prognosis biomarker of Gastrointestinal stromal tumor

Wei Zhuang, Minju Jo, Haibo Qiu, Wanlong Lin, Min Huang, Xueding Wang

Cancer Chemotherapy and Pharmacology · 2025

DOI: 10.1007/s00280-025-04789-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2025. Verfasst von Wei Zhuang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, P.R. China. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Polymorphism, Single Nucleotide, Biomarkers, Tumor, Transcription Factors. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Xiamen Municipality, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal Stromal TumorsPolymorphism, Single NucleotideBiomarkers, TumorTranscription FactorsDNA-Binding ProteinsGastrointestinal NeoplasmsHumansMaleFemaleMiddle AgedImatinib MesylatePrognosisAgedMicroRNAsProgression-Free SurvivalAdultAntineoplastic Agents

Stichwörter der Autor:innen

ETV1Gastrointestinal stromal tumorGenetic polymorphismsImatinibPrognosisSNP

Substanzen

ETV1 protein, humanImatinib MesylateBiomarkers, TumorTranscription FactorsDNA-Binding ProteinsMicroRNAsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, P.R. China.
  • Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, P.R. China.
  • Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, P.R. China.
  • Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, P.R. China. huangmin@mail.sysu.edu.cn.
  • Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, P.R. China. wangxd@mail.sysu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Xiamen Municipality
  • Natural Science Foundation of Fujian Province
  • Young and Middle-aged Talent Cultivation Projects of Xiamen
  • Guangdong Provincial Key Laboratory of Construction Foundation

Zitieren

APA

Zhuang, W., Jo, M., Qiu, H., Lin, W., Huang, M., & Wang, X. (2025). ETV1 genetic polymorphisms as a candidate prognosis biomarker of Gastrointestinal stromal tumor. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-025-04789-2

Vancouver

Zhuang W, Jo M, Qiu H, Lin W, Huang M, Wang X. ETV1 genetic polymorphisms as a candidate prognosis biomarker of Gastrointestinal stromal tumor. Cancer Chemotherapy and Pharmacology. 2025. doi:10.1007/s00280-025-04789-2

BibTeX
@article{Zhuang2025,
  author = {Zhuang, Wei and Jo, Minju and Qiu, Haibo and Lin, Wanlong and Huang, Min and Wang, Xueding},
  title = {ETV1 genetic polymorphisms as a candidate prognosis biomarker of Gastrointestinal stromal tumor},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2025},
  doi = {10.1007/s00280-025-04789-2}
}
Kostenlos starten →